Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: Randomised trial

Additional Metadata
Persistent URL	doi.org/10.1016/S0140-6736(04)17098-0, hdl.handle.net/1765/56137
Journal	The Lancet
Organisation	Department of Medical Oncology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Verweij, J., Casali, P., Zalcberg, J., le Cesne, A., Reichardt, P., Blay, J. Y., Issels, R., van Oosterom, A., Hogendoorn, P., van Glabbeke, M., Bertulli, R.& Judson, I. (2004). Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: Randomised trial. The Lancet, 364(9440), 1127–1134.https://doi.org/10.1016/S0140-6736(04)17098-0

Publication